A single-cell RNA-sequencing analysis showed that classic CD14+ monocytes were significantly increased, whereas nonclassical CD16+ monocytes and intermediate CD14+CD16+ monocytes were remarkably reduced in the blood of COVID-19 patients with severe symptoms. This evidence concerns the gene CD14 and COVID-19.